You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Original Contributions Effects of a Reduced Dose Schedule and Intramuscular Administration of Anthrax Vaccine Adsorbed on Immunogenicity and Safety at 7 Months: A Randomized Trial
Nina Marano; Brian D. Plikaytis; Stacey W. Martin; Charles Rose; Vera A. Semenova; Sandra K. Martin; Alison E. Freeman; Han Li; Mark J. Mulligan; Scott D. Parker; Janiine Babcock; Wendy Keitel; Hana El Sahly; Gregory A. Poland; Robert M. Jacobson; Harry L. Keyserling; Stephen D. Soroka; Sarah P. Fox; John L. Stamper; Michael M. McNeil; Bradley A. Perkins; Nancy Messonnier; Conrad P. Quinn; for the Anthrax Vaccine Research Program Working Group
JAMA 2008; 300: 1532-1543.
[Abstract][Full text][PDF]
Commentaries Nosocomial Infection, the Deficit Reduction Act, and Incentives for Hospitals
From the Centers for Disease Control and Prevention Use of Mass Tdap Vaccination to Control an Outbreak of Pertussis in a High School—Cook County, Illinois, September 2006–January 2007